Royalty Pharma reports second quarter 2026 results
Go back to Royalty Pharma reports second quarter 2026 results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 57.64 +0.87 (1.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $56.77 | 52 Week High | $3.48 | |||
| Open | $57.43 | 52 Week Low | $0.80 | |||
| Day High | $57.83 | P/E | N/A | |||
| Day Low | $56.53 | EPS | $-1.54 | |||
| Volume | 1,411,004 | |||||

